key: cord-1015539-ertr0oye
authors: Gallo, Gloria; Barcick, Uilla; Coelho, Camila; Salardani, Murilo; Camacho, Maurício F.; Cajado-Carvalho, Daniela; Loures, Flávio V.; Serrano, Solange M.T.; Hardy, Leon; Zelanis, André; Würtele, Martin
title: A Proteomics-MM/PBSA Dual Approach for the Analysis of SARS-CoV-2 Main Protease Substrate Peptide Specificity
date: 2022-05-26
journal: Peptides
DOI: 10.1016/j.peptides.2022.170814
sha: 660b2f71be6671c5cea51b1cd5400aa92be9904e
doc_id: 1015539
cord_uid: ertr0oye

The main protease M(pro) of SARS-CoV-2 is a well-studied major drug target. Additionally, it has been linked to this virus’ pathogenicity, possibly through off-target effects. It is also an interesting diagnostic target. To obtain more data on possible substrates as well as to assess the enzyme’s primary specificity a two-step approach was introduced. First, Terminal Amine Isobaric Labeling of Substrates (TAILS) was employed to identify novel M(pro) cleavage sites in a mouse lung proteome library. In a second step, using a structural homology model, the MM/PBSA variant MM/GBSA (Molecular Mechanics Poisson-Boltzmann/Generalized Born Surface Area) free binding energy calculations were carried out to determine relevant interacting amino acids. As a result, 58 unique cleavage sites were detected, including six that displayed glutamine at the P1 position. Furthermore, modeling results indicated that M(pro) has a far higher potential promiscuity towards substrates than expected. The combination of proteomics and MM/PBSA modeling analysis can thus be useful for elucidating the specificity of M(pro), and thus open novel perspectives for the development of future peptidomimetic drugs against COVID-19, as well as diagnostic tools.

Main protease 

SARS-CoV-2 spread worldwide rapidly, initiating the COVID-19 pandemic. Although several effective vaccines and small molecule inhibitors were rapidly developed, COVID-19 remains of great concern to global public health [1, 2] . Due to several issues, including the emergence of new variants of SARS-CoV-2, global efforts for drug discovery to address the disease continue being of uttermost importance.

SARS-CoV-2 is an enveloped (+) single-stranded RNA coronavirus. Its genome size is about 29.9 kb in length. About two thirds of SARS-CoV-2 genome is occupied by orf1ab that encodes the nonstructural proteins, while the remaining region next to the 3" end encodes the structural proteins [3] .

Orf1ab is translated into two polyproteins. They are processed by the virus"s main protease M pro (also called 3CL pro ) and a second papain-like protease (PL pro ) [4] . The structure of M pro from SARS-CoV-2, a protein with 96% sequence identity to M pro from SARS-CoV, was recently solved [5, 6] .

Because of its essential activity in the viral replication machinery, M pro , a cysteine protease, is an excellent target for the rational development of SARS-CoV-2 medications [7] [8] [9] [10] [11] . Additionally, it is considered an interesting marker for diagnostic purposes [12, 13] . Its off-target activity is especially intriguing, as it could be linked to SARS-CoV-2 pathogenicity [14] . For all these reasons, we here have opted for a dualistic approach. First, we employed Terminal Amine Isobaric Labeling of Substrates (TAILS; [15] ) for the identification of M pro cleavage sites in a complex proteome (mouse lung proteome, as described herein). Then, as a second step, molecular modelling techniques via J o u r n a l P r e -p r o o f MM/PBSA free energy calculations were carried out to determine the amino acids that are most relevant for the interaction with protein substrates.

TAILS is an N-terminomic analytical approach that enables the profiling of the substrate repertoire of a given protease (degradome) in complex biological mixtures, therefore allowing subsite mapping based in the use of mass spectrometry and bioinformatics for the identification of (new) Ntermini generated by active proteases. Since the protease is incubated with native substrates in complex biological mixtures such as cell lysates, long-range interactions (e.g. the interaction of protease exosites with their substrates) are potentially allowed under assay conditions. Such a feature is the main advantage of TAILS over approaches involving the incubation of protease with peptide libraries, in which mainly short-range interactions are allowed. Briefly, using dimethyl labeling, prime-side peptides (i.e those that were generated by active proteases in the sample) are labeled at their N-termini, therefore indicating the cleavage site. After the addition of a protease such as trypsin, peptides bearing free N-termini are produced. This latter set of peptides is then sulfo-modified and pulled out from the sample after strong cation exchange chromatography. The resulting peptide set (generated by active proteases in the sample) is submitted to mass spectrometry followed by bioinformatic analyses for protease specificity profiling.

The MM/PBSA and its variant MM/GBSA (Molecular Mechanics Poisson-Boltzmann Surface Area and Molecular Mechanics Generalized Born Surface Area) are popular methods used to determine the free binding energy between a protein and a ligand [16] [17] [18] [19] . Essentially, these methods evaluate the free binding energy of the ligand from MD simulation snapshots using energy terms of the MD force field, but approximating the polar energy terms with the Poisson-Boltzmann (PB) equation, estimating the non-polar energy terms using the solvent-accessible surface area (SASA) method and roughly approximating the entropic terms using normal-mode analysis. They have proven to be reliable methods for the computation of binding energy leading to numerous applications in small-molecule ligand binding and drug design [20] [21] [22] , protein-peptide interactions [23] [24] [25] [26] , protein-protein interactions [27, 28] and protein design [29, 30] . Although their accuracy in some systems is in the order of 10 kJ/mol, both computational improvements in the calculation of individual terms of the binding energy as well as carrying out many short MD simulations [31, 32] has helped obtain more accurate estimations of binding energies up to the 1 kJ/mol range. As a whole, the accuracy of MM/PBSA methods ranks in between more simple semi-empirical molecular docking calculations and more computational demanding alchemical perturbation (AP) methods [33] .

J o u r n a l P r e -p r o o f SARS-CoV-2 M pro (GenBank entry MT358641.1) was synthesized (GenScript, USA) and cloned into the pET21a plasmid to create an expression construct with an N-terminal cleavable His-tag for recombinant expression in E.coli BL21(DE3), purification by affinity chromatography and size exclusion chromatography after cleavage of the His-tag using TEV protease, as previously described [34] .

N-terminome analysis was carried out using the Terminal Amine Isotopic Labeling of Substrates (TAILS) protocol [15] with modifications [35] . A lung lysate from C57BL/6 male mice (n=2) was Trypsin (Proteomics grade, Sigma, USA) was added at a 1:100 ratio (enzyme/substrate) and the mixture was incubated at 37 °C for 18 h. N-terminal peptides were enriched by negative selection using sodium 4-formylbenzene-1,3-disulfonate as described [35] . The peptide mixture was subjected to a three-step disulfomodification procedure [35] . Briefly, 4-formylbenzene -1,3- 

An aliquot (5 μL) of the desalted peptide mixture was injected into a trap column packed with C18 Control) target value of 1,000,000 was set whereas the AGC target value for the fragment ion (MS/MS) spectra was set to 10,000 ions. The lower threshold for targeting precursor ions in the MS scans was 2,000 counts.

Mass spectrometric (RAW) data were analyzed within the Trans Proteomics Pipeline platform [37] ( interval, corresponding to a False Discovery Rate (FDR) of less than 1%.

SARS-CoV-2 M pro models were constructed using homology modeling with the MODELLER software [39] using a M pro peptide complex structure (PDB ID 2Q6G) [40] as a template. This structure contains two chains of SARS-CoV M pro proteins in complex with two TSAVLQSGFRK peptides. For homology modelling, both protomers of the M pro dimer of SARS-CoV-2 were

restrained on their C α atoms to be identical. Similarly, peptides were homology modeled using the peptides from 2Q6G as a template and their C α atoms restrained to be identical.

MD simulations were carried out using the AMBER simulation software package [41] . The model was prepared with tleap using the ff99 AMBER force field, neutralized with Na + ions and solvated

with the TIP3P water model in a cuboid integration box with 12 Å solvent margins. After structure minimization, a short heating run and a density equilibration run, several parallel 10 ns MD production runs were conducted with AMBER. Production runs were carried out with the GPU-J o u r n a l P r e -p r o o f version of pmemd at 300 K in time steps of 2 fs using a constant pressure with isotropic position scaling, Particle Mesh Ewald (PME) model of periodic boundary conditions with an 8 Å classical non-bonded cut-off, a Langevin thermostat and the SHAKE algorithm to constrain the bonds of all hydrogen atoms.

Essentially, a molecular dynamics (MD) simulations of protein-peptide complexes were carried out, and from single snapshots of the MD-trajectory, the binding free energy of the peptides to the protein ∆ was calculated from protein-peptide complex MD simulations as an averaged difference between the free energies of the complex state ⟨ ⟩ and unbound states of the protein ⟨ ⟩ and the peptide ligand ⟨ ⟩:

The states were evaluated using following approximation: Finally, is the entropic term, which was approximated using normal mode analysis [41] [42] [43] . In detail, the MM/GBSA calculations were carried with the AMBER MMPBSA.py script [41] using the "OBC" model (igb=2) [44] together with mbondi2 atomic radii. At least 20 independent 10 ns production runs were carried out for each peptide. For each run, 25 snapshots for ΔH GBSA and 5 snapshots for TΔS calculations were evaluated. After averaging results, error values were calculated as SEM (Standard Error of the Mean) from the independent runs. 

The N-terminomic analysis of the proteolytic activity of M pro upon a mouse lung proteome library resulted in the identification of 58 unique cleavage sites. Thus, 58 peptides, which were absent in the control condition, were identified as heavy dimethylated-labeled (singleton) peptides (Error! Reference source not found. and Error! Reference source not found.). Interestingly, out of the 58 unique cleavage sites, six contained Glutamine (Q) at the P1 position ( Table 1 ). The cleaved proteins include contactin-associated protein like 5-3, a protein that is likely involved in cell adhesion and intracellular communication in the central nervous system; FIP1, a protein involved in pre-mRNA 3'-end-processing; F-box only protein 43, which is possibly involved in ubiquitinationmediated regulatory complexes [45] ; golgin subfamily A member 4, a protein that is associated with vesicular trafficking by the Golgi apparatus, and collagen alpha-1(XXVIII) chain, which is possibly involved in damage repair processes [46] . These proteins might be bona fide substrates of M pro .

However, the physiological implications of their cleavage must be further validated. Thus, we chose to focus on structural aspects of M pro subsite specificity. The primary specificity of M pro for residues containing a Glutamine at the P1 position was also observed in recent reports on M pro cleavage specificity [14, 47] and is in accordance with the primary specificity observed for SARS-CoV-2 and SARS-CoV main proteases [5, 6, 48] . Recent Nterminomics reports on M pro specificity used a protease to proteome ratio ranging from 1:20 to 1:10 [14, 47] , whereas in this work we used a protease to proteome ratio of 1:50. This might explain why we identified fewer cleavage sites spanning the canonical M pro preference of Q at P1. Moreover, for the cleavage sites containing Q at P1 position, we did not verify the recurrent presence of L at P2, as recently reported [14 ,45] . On the other hand, most cleavage sites (~90%) varied in relation to the residues at the scissile bond (P1-P1' positions), and, notably, they deviated from the canonical J o u r n a l P r e -p r o o f presence of Q at P1 position in the set of identified peptides. In this context, we cannot rule out the activation of other proteases of mouse lung tissue upon incubation with M pro , therefore resulting in peptides spanning distinct cleavage sites (i.e. other than Q at P1). Thus, we focused our structural analysis on peptides in which the preference of Q at P1 was observed ( Table 1) .

In order to estimate the free binding energy of the different detected M pro binding peptides, MM/GBSA analysis was performed. To obtain reproducible data several 10 ns MD production runs were carried out. The obtained snapshots were then analyzed via AMBER"s MMPBSA.py script. As a result, reproducible averaged free energy calculations with SEM values in the order of 1 to 2 kcal/mol could be obtained. The M pro binding peptides together with their main MM/GBSA energy components are shown in Table 2 . The obtained free binding energies are in a similar order of magnitude with those in a recent study of peptides interacting with the Zika virus protease.

Interestingly, in that study, a significant correlation between free binding energies calculated with MM/PBSA and experimentally measured Michaelis-Menten constants K m was obtained [23] . Table 2 . MM/GBSA analysis of M pro binding peptides. The main energy components from the MM/GBSA calculations ∆ , the conformational entropy term ∆ , as estimated with normal mode analysis and the total free binding energy ∆ are given in kcal/mol. complementarity to the corresponding peptides, with particularly tight S1, S2 and S4 binding pockets. Contrasting with this, the S1", S2", S4" and particularly the S3 and S3" binding pockets are

wider and more open with higher solvent exposure. The corresponding peptides bind with tight interactions to their respective S-sites through their P1, P2 and P4 side chains. The P3 and P5 side chains are mostly oriented towards the solvent. The C-terminal peptide half binds in a more solvent exposed mode, with P1", P2" and P4" interacting with the more open and solvent exposed S1", S2" and S4" sites. The P3" and P5" side chains are mostly solvent exposed.

Concerning the electrostatic potential surface, the N-terminal binding sites show a more negative electrostatic potential at the sites binding the N-terminal portion of the peptide (   Fig. 1) . Concerning the modeling of electrostatic binding enthalpies in the MM/GBSA studies of the peptides, more favorable electrostatics of peptide binding are mostly compensated by less favorable peptide polar solvation energies ( Table 3) . This indicates that peptide binding of M pro is not determined exclusively by electrostatics, at least not in the MM/GBSA model applied.

J o u r n a l P r e -p r o o f Table 3 . MM/GBSA energy components. Different energy components from the MM/GBSA analysis of the binding of the peptides displaying the canonical Gln at P1 position to SARS-CoV-2 M pro are given in kcal/mol.

To further discern the importance of the amino acids to the free energy of binding, binding energy decomposition analysis was carried out with the AMBER MMPBSA.py script. The obtained results

can be considered a measure of the interaction energy of each amino acid with the rest of the system. They are shown in Fig. 2 . In this figure, the importance of the P1 and P2 residues, for peptide recognition by M pro become apparent. To complement this analysis, in Fig. 3 Of the six peptides found in the mass spectrometry analysis containing the canonical Q at the P1 position, the modeled GAEIQDGRFN peptide shows average interacting affinity, as shown by the calculated ΔG value (-26.6 kcal/mol, Table 2 ). Per-residue binding energy decomposition analysis shows strong interaction of the protein with the P2 Ile and P1 Gln side chains and to a lesser degree with the P4" Phe and P4 Ala side chains ( Fig. 2A) .

Compared to this peptide, the GETEQKRIRK peptide shows a similar binding affinity (ΔG = -26.8

kcal/mol) in the modeling studies. In this case, the per-residue MM/GBSA energy decomposition analysis indicates that the less favorable substitutions Ile/Glu (at P2), Ala/Glu (P4) and Phe/Arg (P4") are mostly countered by several more favorable substitutions (e.g. Glu/Thr at P3, Asp/Lys at P1" and Gly/Arg at P2", Fig. 2A and Fig. 2B ). Analyzing the ligand MM/GBSA energy components, improvement of the electrostatics for binding (ΔE el ) is reversed by less favorable polar solvent free energies (ΔG polar , Table 3 ). On the side of the protein, electrostatics are more favorable in comparison with the GAEIQDGRFN peptide. However, the resulting more favorable MM/GBSA binding energy term (ΔH GBSA ) is weakened by a more unfavorable -TΔS value ( Table 3) . Entropy evaluations with MM/PBSA or MM/GBSA methods must be interpreted carefully, due to obvious methodological limitations [16] . In the current analysis, most peptides showed however a similar conformational entropy (-TΔS) value of about 41.8 kcal/mol. Because this -TΔS value is similar, the task of ranking the binding can be thus in most cases simplified in first approximation to comparison of the other binding energy values. The somewhat atypical -TΔS value of 47.5 kcal/mol for the GETEQKRIRK peptide is possibly the result of its increased number of large, positively charged residues, which will induce more vibrational and rotational movements, including sidechain rotamer states [49, 50] . These states are stabilized upon binding, leading to a reduction of conformational entropy. This effect is expected to be very significant when these residue sidechains bind to the interface of a protein. This is certainly the case of the all the three interacting residues of the KRIRK sequence, except the last lysine, which presumably remains mostly solvent exposed after peptide binding.

Compared with GAEIQDGRFN, the KRSQQEDDQE peptide binding energy decomposition shows binding energy improvements due mostly to the Ala/Arg (at P4) that are however compensated by

Ile/Gln(P2) and Phe/Gln (P4") substitutions (Fig. 2C) . Similar to GETEQKRIRK, the MM/GBSA energy components ( 

The QLNSQLFVGG is the peptide with the most favorable ΔG value (-35.9 kcal/mol). Compared with GAEIQDGRFN, the most important favorable substitution is Ala to Leu at P4, which apparently fills the S4 subsite"s steric restrains better. The other improvements are at the P1" (Asp to Leu), P2"

(Gly to Phe) and P3" (Arg to Val) sites (Fig. 2D) . On the other hand, QLNSQLFVGG has some less favorable substitutions at the P2 (Ile to Ser) and P4" (Phe to Gly) positions.

The last two peptides considered in this study are SSPSQSGDTQ (ΔG = -16.3 kcal/mol) and SSSVQIDPPL (ΔG = -24.5 kcal/mol). In the case of the below average ΔH GBSA of SSPSQSGDTQ, MM/GBSA binding energy decomposition indicates most disadvantages in comparison with GAEIQDGRFN are due to an Ile/Ser substitution at P2 position and a Phe/Thr substitution at P4" position ( Fig. 2E) . In the case of SSSVQIDPPL, which has a slightly less favorable binding enthalpy when compared with GAEIQDGRFN, MM/GBSA binding enthalpy indicates only slight improvements mainly through the P1" Asp to Ile substitution in energy decomposition analysis (Fig.   2F ). However, these small improvements are reversed by decrements in negative binding enthalpy in the protein part of the decomposition. These decrements are mostly related to both more unfavorable electrostatics (ΔE el and ΔG polar ) and Van der Waals (ΔE VdW ) contacts being involved in the binding of the SSSVQIDPPL peptide ( Table 3 ).

In conclusion, peptide binding to the M pro active site does not seem to be driven mainly by 

The obtained results indicate that the ΔH GBSA energy term can be significantly improved by 

Additionally to the canonical peptides, MM/GBSA analysis was carried out with all the noncanonical peptides (i.e. peptides without a Q at P1) identified in TAILS analysis (Error! Reference source not found. and Error! Reference source not found.). Interestingly, these peptides showed an table S4 were partially corroborated by experimental peptide library cleavage data [51] and the native viral sequences cleaved by M pro [10] in that e.g. our MM/GBSA studies indicate Leu in position P2 as one of the 3 top binders and Arg is the top binding amino acid in P3.

Obtaining kinetical data from binding studies of substrates to proteases must be viewed with caution, as the binding of substrate is not usually the rate limiting step of the reaction. This can be exemplified in an extreme case by the well-studied peptidic protease inhibitors [52] . Another limitation of this study is related to the possibility that some of the detected peptides might have been generated by lung tissue proteases after incubation with M pro . Notwithstanding, the modelling 

Current status of structure-based drug repurposing against COVID-19 by targeting SARS-CoV-2 proteins

Drug targets for COVID-19 therapeutics: Ongoing global efforts

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design

Structure of M pro from SARS-CoV-2 and discovery of its inhibitors

Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors

Structural Basis of Potential Inhibitors Targeting SARS-CoV-2 Main Protease

Medicinal chemistry strategies towards the development of effective SARS-CoV-2 inhibitors

Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors

The SARS-CoV-2 main protease as drug target

Approved Antiviral Drugs over the Past 50 Years

Activatable Carbocyanine Dimers for Photoacoustic and Fluorescent Detection of Protease Activity

COVID-19 Biomarkers and Advanced Sensing Technologies for Point-of-Care (POC) Diagnosis

Mechanistic insights into COVID-19 by global analysis of the SARS-CoV-2 3CLpro substrate degradome

Identifying and quantifying proteolytic events and the natural N terminome by terminal amine isotopic labeling of substrates

The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities

Free energy calculations on dimer stability of the HIV protease using molecular dynamics and a continuum solvent model

Continuum Solvent Studies of the Stability of DNA, RNA, and Phosphoramidate−DNA Helices

What is the current value of MM/PBSA and MM/GBSA methods in drug discovery?

Improving virtual screening results with MM/GBSA and MM/PBSA rescoring

Assessing the performance of MM/PBSA and MM/GBSA methods 9 Prediction reliability of binding affinities and binding poses for protein-peptide complexes

Application of MM-PBSA Methods in Virtual Screening

Binding recognition of substrates in NS2B/NS3 serine protease of Zika virus revealed by molecular dynamics simulations

Dynamics and binding interactions of peptide inhibitors of dengue virus entry

Molecular modeling of hair keratin/peptide complex: Using MM-PBSA calculations to describe experimental binding results

Probing the mechanism of peptide binding to REV response element RNA of HIV-1; MD simulations and free energy calculations

Improving the Performance of MM/PBSA in Protein-Protein Interactions via the Screening Electrostatic Energy

Characterizing the stabilization effects of stabilizers in protein-protein systems with end-point binding free energy calculations

End-Point Binding Free Energy Calculation with MM/PBSA and MM/GBSA: Strategies and Applications in Drug Design

Investigation of structural analogs of hydroxychloroquine for SARS-CoV-2 main protease (Mpro): A computational drug discovery study

Calculating Structures and Free Energies of Complex Molecules: Combining Molecular Mechanics and Continuum Models

Binding selectivity of inhibitors toward the first over the second bromodomain of BRD4: theoretical insights from free energy calculations and multiple short molecular dynamics simulations

Recent theoretical and computational advances for modeling protein-ligand binding affinities

Biochemical screening for SARS-CoV-2 main protease inhibitors

Enrichment of protein N-termini by charge reversal of internal peptides

Protocol for micro-purification, enrichment, prefractionation and storage of peptides for proteomics using StageTips

Trans-Proteomic Pipeline, a standardized data processing pipeline for large-scale reproducible proteomics informatics

Comet: An open-source MS/MS sequence database search tool

Modeller: Generation and Refinement of Homology-Based Protein Structure Models

Structures of Two Coronavirus Main Proteases: Implications for Substrate Binding and Antiviral Drug Design

The Amber biomolecular simulation programs

An overview of the Amber biomolecular simulation package: Amber biomolecular simulation package

Exploring protein native states and large-scale conformational changes with a modified generalized born model

Mammalian Emi2 mediates cytostatic arrest and transduces the signal for meiotic exit via Cdc20

Biochemistry of Collagens, Laminins and Elastin

N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease

Characterization and Inhibition of the Main Protease of Severe Acute Respiratory Syndrome Coronavirus

Crystal structure of Thermus thermophilus methylenetetrahydrofolate dehydrogenase and determinants of thermostability

Dynamic cross correlation analysis of Thermus thermophilus alkaline phosphatase and determinants of thermostability

SARS-CoV-2 Mpro inhibitors and activitybased probes for patient-sample imaging

Mechanisms of Macromolecular Protease Inhibitors